The pharmaceutical field is seeing a major shift in diabetes care with the arrival of GLP-1 skin applications. These innovative vehicles offer a likely convenient alternative to injections for individuals managing type 2 diabetes. By circumventing the necessity for frequent needles, GLP-1 adhesiv